CVE-2022-48225

Name: CVE-2022-48225
Creator: NVD / NIST
Published: 2023-04-04T15:15:08.757+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

HIGHCVSS 7.3/10EPSS 0.20%

Last modified Jun 17, 2026

CVE-2022-48225 is a high-severity vulnerability rated 7.3/10 on the CVSS scale. An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is used to install drivers from several different vendors. EPSS estimates a 0.20% chance of exploitation in the next 30 days.

Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is used to install drivers from several different vendors. The Gemalto Document Reader child installation process is vulnerable to DLL hijacking, because it attempts to execute (with elevated privileges) multiple non-existent DLLs out of a non-existent standard-user writable location.

Metrics

CVSS 3.1

7.3/10

CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H

EPSS Probability

0.20%

9.8th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-427

Affected Software

Vendor	Product	Versions
Gbgplc	Acuant Acufill Sdk	< 10.22.02.03

References

https://acuant.comNot Applicable
https://hackandpwn.com/disclosures/CVE-2022-48225.pdfThird Party Advisory
https://acuant.comNot Applicable
https://hackandpwn.com/disclosures/CVE-2022-48225.pdfThird Party Advisory

Timeline

Published: Apr 4, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2022-48225?

How severe is CVE-2022-48225?

CVE-2022-48225 has a CVSS score of 7.3/10 (HIGH severity). The EPSS model estimates a 0.20% probability of exploitation in the next 30 days.

How do I fix CVE-2022-48225?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-48225?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST